Scientific comment on: "Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon". Who likes to take medicine forever?
AUTOR(ES)
Bendit, Israel
FONTE
Hematol., Transfus. Cell Ther.
DATA DE PUBLICAÇÃO
10/06/2019
RESUMO
Documentos Relacionados
- Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon
- Adherence to treatment with imatinib in chronic myeloid leukemia: a study of the first decade of responses obtained at a Brazilian hospital
- Comment on: determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
- Chronic myeloid leukemia: an overview of the determinants of effectiveness and therapeutic response in the first decade of treatment with imatinib mesylate in a Brazilian hospital
- Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia